June 24, 2014
Pfizer Japan announced on June 20 that it has obtained an additional indication for the prevention of pneumococcal infection in the elderly for the precipitated 13-valent conjugate vaccine Prevenar 13. Prevenar 13 is already indicated for the prevention of invasive...read more